Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Jean-Pierre Déry"'
Autor:
Marc-André d’Entremont, MD, MPH, Christina C. Wee, MD, MPH, Michel Nguyen, MD, Étienne L. Couture, MD, MPH, Samuel Lemaire-Paquette, MSc, Simon Kouz, MD, MSc, Marc Afilalo, MD, Stéphane Rinfret, MD, SM, Erick Schampaert, MD, Samer Mansour, MD, Martine Montigny, MD, MSc, Mark Eisenberg, MD, MPH, Claude Lauzon, MD, Jean-Pierre Déry, MD, MSc, Philippe L’Allier, MD, Jean-Claude Tardif, MD, Thao Huynh, MD, MSc, PhD
Publikováno v:
CJC Open, Vol 3, Iss 12, Pp S28-S35 (2021)
Background: Although prior studies have demonstrated racial disparities regarding acute coronary syndrome (ACS) care within private or mixed healthcare systems, few researchers have explored such disparities within universal healthcare systems. We ai
Externí odkaz:
https://doaj.org/article/f475610e092347b2a4fabe51f7d7f52a
Autor:
Carol Anne Graham, Mary K. Tan, Derek P. Chew, Christopher P. Gale, Keith A. A. Fox, Akshay Bagai, Mark A. Henderson, Ata ur Rehman Quraishi, Jean-Pierre Déry, Asim N. Cheema, Harold Fisher, David Brieger, Sohrab R. Lutchmedial, Shahar Lavi, Brian Y. L. Wong, Tomas Cieza, Shamir R. Mehta, Neil Brass, Shaun G. Goodman, Andrew T. Yan
Publikováno v:
Heart and Vessels. 37:1291-1298
Autor:
Shaun G. Goodman, Gerald Simkus, Mark J. Eisenberg, Mina Madan, Akshay Bagai, Jean-François Tanguay, Samer Mansour, Felipe H. Valle, Andrew T. Yan, Benoit Daneault, Jean Grégoire, Derek So, Christopher B. Overgaard, Jean-Michel Paradis, Stéphane Rinfret, Kevin R. Bainey, Jean-Pierre Déry, Mary Tan, B. Har, Razi Khan, Basem Elbarouni, Robert C. Welsh, Ata-Ur-Rehman Quraishi, J. Schwalm, Robert De Larochellière, Madhu K. Natarajan, Andrew C.T. Ha, Brian J. Potter, Joseph Abunassar
Publikováno v:
CJC Open
CJC Open, Vol 3, Iss 12, Pp 1419-1427 (2021)
CJC Open, Vol 3, Iss 12, Pp 1419-1427 (2021)
Background: In patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI), selecting an antithrombotic regimen requires balancing risks of ischemic cardiac events, stroke, and bleeding. Methods: We studied 467 patients
Autor:
Jean-Pierre Déry, Yaron Arbel, Payam Dehghani, Ashish Patel, Christopher B. Fordyce, Mina Madan, Shahar Lavi, Colin Barry, Sean Jedrzkiewicz, Robert S. McKelvie, Andrew L. Mathew, Michael Heffernan, Mary K. Tan, Andrea Lavoie, Razi Kahn, Firas Ahmed, Thao Huynh, Neville Suskin, Shaheeda Ahmed, Akshay Bagai, Sohrab Lutchmedial, Andrew T. Yan, Shaun G. Goodman
Publikováno v:
CJC Open
CJC Open, Vol 3, Iss 12, Pp 1463-1470 (2021)
CJC Open, Vol 3, Iss 12, Pp 1463-1470 (2021)
Background: Extension of dual antiplatelet therapy (DAPT) beyond 1 year after acute coronary syndrome is associated with a reduction in ischemic events but also increased bleeding. The DAPT score identifies individuals likely to derive overall benefi
Autor:
Akshay Bagai, Shaun G. Goodman, Hahn Hoe Kim, Andrew T. Yan, Andrea Lavoie, Christopher B. Fordyce, Ashish Patel, Nathan W. Brunner, Tara Sedlak, Sean Jedrzkiewicz, Saleem Kassam, Roger K. Philipp, Sohrab Lutchmedial, Shahar Lavi, Mina Madan, Thao Huynh, Sam Radhakrishnan, Michael Heffernan, Andrew L Mathew, Mary Tan, Jean-Pierre Déry, Payam Dehghani, Robert McKelvie, Neville Suskin, Colin Barry, Tomas Cieza, Razi Khan, Shaheeda Ahmed
Publikováno v:
Clinical Cardiology. 44:839-847
BACKGROUND After myocardial infarction, guidelines recommend higher-potency P2Y12 receptor inhibitors, namely ticagrelor and prasugrel, over clopidogrel. HYPOTHESIS We aimed to determine the contemporary use of higher-potency antiplatelet therapy in
Autor:
Carol Anne, Graham, Mary K, Tan, Derek P, Chew, Christopher P, Gale, Keith A A, Fox, Akshay, Bagai, Mark A, Henderson, Ata Ur Rehman, Quraishi, Jean-Pierre, Déry, Asim N, Cheema, Harold, Fisher, David, Brieger, Sohrab R, Lutchmedial, Shahar, Lavi, Brian Y L, Wong, Tomas, Cieza, Shamir R, Mehta, Neil, Brass, Shaun G, Goodman, Andrew T, Yan
Publikováno v:
Heart and vessels. 37(8)
Chronic kidney disease (CKD) increases the risk of adverse outcomes in acute coronary syndrome (ACS). The optimal regimen of dual antiplatelet therapy (DAPT) post-percutaneous coronary intervention (PCI) in CKD poses a challenge due to the increased
Autor:
Sanam Verma, William Keeble, Rajendra M Chetty, Wayne J. Tymchak, David Laflamme, Michael C Hartleib, Tomas Cieza, Andy S. Lam, Dinkar Shukla, Randi C Rose, Christian Constance, Grace L Chua, Bruce J Lubelsky, Brian J. Potter, Razi Khan, Robert C. Welsh, Richard Choi, Kevin R. Bainey, Samer Mansour, Jean-Pierre Déry, Benoit Daneault, Shaun G. Goodman, Mary K. Tan
Publikováno v:
International Journal of Clinical Practice. 75
BACKGROUND Although acetylsalicylic acid is the most commonly used antithrombotic agent for the secondary prevention of cardiovascular events, residual atherothrombotic risk has prompted a guideline recommendation for the addition of dual antiplatele
Autor:
Martine Montigny, Jean-Claude Tardif, Michel Nguyen, Claude Lauzon, Philippe L. L’Allier, Christina C. Wee, Marc Afilalo, Samer Mansour, Mark J. Eisenberg, Samuel Lemaire-Paquette, E. Schampaert, Simon Kouz, Jean-Pierre Déry, Thao Huynh, Etienne L Couture, Marc-André d’Entremont, Stéphane Rinfret
Publikováno v:
CJC Open, Vol 3, Iss 12, Pp S28-S35 (2021)
CJC Open
CJC Open
Background: Although prior studies have demonstrated racial disparities regarding acute coronary syndrome (ACS) care within private or mixed healthcare systems, few researchers have explored such disparities within universal healthcare systems. We ai
Autor:
Michiaki Kubo, Tobias Geisler, Dimitrios Alexopoulos, Gian Franco Gensini, Kiyuk Chang, Jean-Luc Reny, Joshua P. Lewis, Meinrad Gawaz, Elke Schaeffeler, Kevin P. Bliden, Stefan Winter, Eun Young Kim, Ruth E. Pakyz, Paul A. Gurbel, Rossella Marcucci, Israel Fernandez-Cadenas, Joan Montaner, Nadia Paarup Dridi, Li Gong, Jae-Gook Shin, Matthias Schwab, Ryan Whaley, Jurriën M. ten Berg, John H. Cleator, Pierre Fontana, Marco Valgimigli, Russ B. Altman, Ho-Sook Kim, Joshua D. Backman, Jolanta M. Siller-Matula, Daniel Aradi, Braxton D. Mitchell, Betti Giusti, Thomas O. Bergmeijer, Kathleen A. Ryan, Alan R. Shuldiner, Ming-Shien Wen, Jean-Pierre Déry, Marylyn D. Ritchie, Teri E. Klein, Dan M. Roden, Ming Ta Michael Lee, Dietmar Trenk, Gianluca Campo, Lene Holmvang, Willibald Hochholzer
Publikováno v:
Eur Heart J Cardiovasc Pharmacother
Aims Clopidogrel is prescribed for the prevention of atherothrombotic events. While investigations have identified genetic determinants of inter-individual variability in on-treatment platelet inhibition (e.g. CYP2C19*2), evidence that these variants
Autor:
Akshay Bagai, Derek So, R. Khan, Jason G. Andrade, R Maranda, A Hameed, P Nadeau, S. Lavi, M. Le May, V Ahooja, Kevin R. Bainey, M Paniagua, H. Kim, Andrew T. Yan, Benoit Daneault, A Lam, B. Har, A Glanz, D Gao, Mark J. Eisenberg, A Yip, Aun-Yeong Chong, Jean Grégoire, Jean-Michel Paradis, C. Spindler, Zachary Laksman, Tomas Cieza, Jean-Pierre Déry, P Malek-Marzban, Basem Elbarouni, W.J. Cantor, J. Schwalm, Brett Heilbron, Alexis Matteau, R Tahiliani, Robert C. Welsh, H Bonakdar, Mary Tan, S Roth, M Doucet, D Yung, Mina Madan, S.G. Goodman, L Noronha, Simon D. Robinson
Publikováno v:
Canadian Journal of Cardiology. 37:S6-S7
BACKGROUND The Coordinated National Network to Engage Cardiologists in the antithrombotic Treatment of patients with Atrial Fibrillation undergoing Percutaneous Coronary Intervention (CONNECT AF+PCI-I) program provided a snapshot (Nov 2015-Jul 2018)